解整合素金屬蛋白酶28(ADAM28)多克隆抗體
Polyclonal Antibody to A Disintegrin And Metalloprotease 28 (ADAM28)
ADAM23; MDCL; eMDCII; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L; Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II
- 編號PAK202Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPK202Hu01-解整合素金屬蛋白酶28(ADAM28)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 630¥ 1470¥ 2100¥ 5250¥ 21000
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
IHC圖
WB圖
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對ADAM28的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別ADAM28。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPK202Hu01 | 解整合素金屬蛋白酶28(ADAM28)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAK202Hu01 | 解整合素金屬蛋白酶28(ADAM28)多克隆抗體 | WB; IHC; ICC; IP. |
| MAK202Hu21 | 解整合素金屬蛋白酶28(ADAM28)單克隆抗體 | WB; IHC; ICC; IP. |
| SEK202Hu | 解整合素金屬蛋白酶28(ADAM28)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMK202Hu | 解整合素金屬蛋白酶28(ADAM28)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Rapid Communications in Mass Spectrometry | Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma[Pubmed: 21913264] |
| Medical Oncology | Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor[SpringerLink: kg628446760r60rl] |
| Immunology & Cell Biology | ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α.[PubMed: 23010875] |
| Leuk Res | ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in[PubMed: 26340916] |
| Disease Markers | Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results[Pubmed: 31565100] |